Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 25 November 2021
EventHumanCOVID-19Vaccines
Latvian is available via eTranslation, the European Commission's machine translation service.
Translate to Latvian | Important information about machine translation
Date
- Ceturtdiena, 25 Novembris 2021, Visu dienu
Vieta
- OnlineEuropean Medicines Agency, Amsterdam, the Netherlands
This extraordinary meeting is organised to discuss the evaluation of an application to extend the use of Comirnaty, a vaccine for COVID-19 developed by BioNTech and Pfizer, to include children aged 5 to 11.
EMA will communicate on the outcome of the meeting.
The Committee for Medicinal Products for Human Use (CHMP) is responsible for preparing the European Medicines Agency's opinions on all questions concerning human medicines.